| PERIOD ENDING | 26-Sep-09 | 27-Jun-09 | 31-Mar-09 | 27-Dec-08 | | Total Revenue | 8,820 | 7,913 | 8,317 | 8,398 | | Cost of Revenue | 5,939 | 5,436 | 6,927 | 5,652 | | | Gross Profit | 2,882 | 2,476 | 1,390 | 2,746 | | | Operating Expenses | | Research Development | 540 | 306 | 655 | 484 | | Selling General and Administrative | 1,813 | 2,024 | 2,036 | 1,967 | | Non Recurring |
-
|
-
|
-
| 9,260 | | Others | 87 | 87 | 67 | 150 | | | | Total Operating Expenses |
-
|
-
|
-
| 11,860 | | | | Operating Income or Loss | 442 | 59 | (1,368) | (9,114) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (249) | 50 | 5 | (107) | | Earnings Before Interest And Taxes | 193 | 110 | (1,362) | (9,222) | | Interest Expense | (130) | 130 | 99 | 90 | | Income Before Tax | 323 | (21) | (1,461) | (9,312) | | Income Tax Expense | 137 | (9) | (1,191) | 72 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 186 | (12) | (270) | (9,384) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 186 | (12) | (270) | (9,384) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $186 | ($12) | ($270) | ($9,384) |
|
0.06% Nasdaq 
Income Statement
